Details for Patent: 9,770,407
✉ Email this page to a colleague
Which drugs does patent 9,770,407 protect, and when does it expire?
Patent 9,770,407 protects CARNEXIV and is included in one NDA.
This patent has twenty-four patent family members in seventeen countries.
Summary for Patent: 9,770,407
Title: | Parenteral carbamazepine formulation |
Abstract: | The present invention is directed to a carbamazepine-cyclodextrin inclusion complex useful for the parenteral administration of carbamazepine. The carbamazepine-cyclodextrin inclusion complex is prepared by the admixture of a modified cyclodextrin and carbamazepine in a physiologically acceptable fluid. Modified cyclodextrins include 2-hydroxypropyl-beta-cyclodextrin and sulfoalkyl cyclodextrins. More particularly, the sulfoalkyl cyclodextrins are those described and disclosed in U.S. Pat. Nos. 5,134,127 and 5,376,645. A physiologically acceptable fluid includes sterile isotonic water, Ringer's lactate, D5W (5% dextrose in water), physiological saline, and similar fluids suitable for parenteral administration. |
Inventor(s): | Cloyd; James (Edina, MN), Birnbaum; Angela (Minneapolis, MN), Leppik; Ilo (Minneapolis, MN), Collins; Stephen D. (Lake Forest, IL) |
Assignee: | LUNDBECK PHARMACEUTICALS LLC (Deerfield, IL) |
Application Number: | 14/051,938 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,770,407 |
Patent Claim Types: see list of patent claims | Composition; Delivery; |
Drugs Protected by US Patent 9,770,407
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,770,407
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2006299501 | ⤷ Try a Trial | |||
Brazil | PI0616447 | ⤷ Try a Trial | |||
Canada | 2624463 | ⤷ Try a Trial | |||
China | 101309691 | ⤷ Try a Trial | |||
Cyprus | 1115517 | ⤷ Try a Trial | |||
Denmark | 1928464 | ⤷ Try a Trial | |||
European Patent Office | 1928464 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |